Combination of perindopril/indapamide in secondary prevention of stroke and other vascular events: A combined analysis of ADVANCE, PROGRESS and HYVET trials

Sarkar, Sougat S.
June 2011
Bangladesh Journal of Pharmacology;Jun2011, Vol. 6 Issue 1, p25
Academic Journal
Perindopril/indapamide combination has been shown to reduce cardiovascular risk in different groups of patients. A total of 18,529 patients (9,272 receiving perindopril/indapamide and 9,257 receiving placebo) were included in this meta-analysis involving three large randomized clinical trials-ADVANCE, PROGRESS and HYVET. A non-significant reduction in fatal and non-fatal stroke was seen (Odds ratio 0.73; 95% Confidence Interval 0.49 to 1.09; z=1.52 and p= 0.13). The fixed combination perindopril and indapamide was associated with a significant reduction of vascular death (Odds ratio 0.79; 95% Confidence Interval 0.69 to 0.90; z=3.48 and p=0.0005) and major cardiovascular events (Odds ratio 0.72; 95% Confidence Interval 0.53 to 0.97; z=2.15 and p= 0.03). However, effect on stroke needs further evaluation.


Related Articles

  • Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis. Wolfrum, Mathias; Froehlich, Georg M.; Knapp, Guido; Casaubon, Leanne K.; DiNicolantonio, James J.; Lansky, Alexandra J.; Meier, Pascal // Heart;Mar2014, Vol. 100 Issue 5, p389 

    Context: The role of percutaneous closure of patent foramen oval (PFO) in patients with cryptogenic stroke has been very controversial for years due to a lack of clear evidence. Objective: Systematic review and meta-analysis of the effect of percutaneous PFO closure for secondary prevention of...

  • Impact of a Better Persistence with Antihypertensive Agents on Ischemic Stroke Outcomes for Secondary Prevention. Xu, Jie; Zhao, Xingquan; Wang, Yilong; Wang, Chunxue; Liu, Liping; Sun, Baoying; Wang, Anxin; Wang, Yongjun // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Background: The efficacy of antihypertensive (AH) treatment after stroke has been investigated in several randomized clinical trials. However, non-adherence to AH medication is common for stroke patients in “real world” setting. The purpose of this study was to assess the impact of...

  • CITATIONS AND CLINICIANS' NOTES: Stroke Prevention.  // Current Medical Literature: Stroke Review;2005, Vol. 9 Issue 1, p149 

    Presents articles about stroke prevention which may be useful for clinicians. "Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials," by J. Leonardi-Bee, P.M. Bath, M.G. Bousser et al.;...

  • Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. Fields, Jeremy D.; Khatri, Pooja; Nesbit, Gary M.; Liu, Kenneth C.; Barnwell, Stanley L.; Lutsep, Helmi L.; Clark, Wayne M.; Lansberg, Maarten G. // Journal of NeuroInterventional Surgery;Jun2011, Vol. 3 Issue 2, p151 

    The article discusses a meta-analysis performed on randomized clinical trials of intra-arterial administration of thrombolytics (IAT) in the treatment of middle cerebral artery (MCA) stroke to precisely estimate the effect of IAT on several key clinical endpoints. The analysis showed that all...

  • Bench to bedside: the quest for quality in experimental stroke research. Dirnagl, Ulrich // Journal of Cerebral Blood Flow & Metabolism;Dec2006, Vol. 26 Issue 12, p1465 

    Over the past decades, great progress has been made in clinical as well as experimental stroke research. Disappointingly, however, hundreds of clinical trials testing neuroprotective agents have failed despite efficacy in experimental models. Recently, several systematic reviews have exposed a...

  • Warfarin Better for Atrial Fibrillation Patients. Elliott, William T. // Clinical Cardiology Alert;Aug2007, Vol. 26 Issue 8, p2 

    The article discusses research being done on the effect of warfarin on patients with atrial fibrillation. It references a study published in a 2007 issue of the "Annals of Internal Medicine." The authors conducted a meta-analysis, which found that warfarin can prevent stroke in patients with...

  • Carotid Arterial Dissection: Time for a Randomized Clinical Trial. Caronna, John J. // Neurology Alert;Dec2008, Vol. 27 Issue 4, p28 

    CEREBRAL ARTERIAL DISSECTION IS AN IMPORTANT cause of stroke, especially in the young. Potential stroke mechanisms include both hemodynamic compromise and embolism. Evidence from cerebral angiography and transcranial Doppler studies suggests that embolism is the more important cause of stroke....

  • Does Lipid Lowering Decrease Stroke Risk? Shaughnessy, Allen F. // American Family Physician;4/15/2005, Vol. 71 Issue 8, p1595 

    Reviews the study "Effects of Statins on Stroke Prevention in Patients With and Without Coronary Heart Disease: A Meta-analysis of Randomized Controlled Trials," by M. Briel and colleagues, published in the October 15, 2004 issue of "The American Journal of Medicine." Clinical question...

  • Calcium channel blockers best against stroke risk. Baines, Emma // GP: General Practitioner;10/8/2004, p8 

    The article focuses on a review of existing trial data that states that Calcium channel blockers are more effective than other antihypertensives at reducing the risk of stroke. Researchers from Italy and Belgium carried out a meta-analysis of 13 trials comparing treatments for hypertension. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics